ArticleScientific reports2025
Revolutionizing proton exchange membrane fuel cell modeling through hybrid aquila optimizer and arithmetic algorithm optimization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Escaping the Scaling Relationships in Oxygen Reduction Catalysis: Implications for PEM Fuel Cells.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Enhanced Osprey Optimization Algorithm for Global Optimization with Application to PEM Fuel Cell Parameter Identification.Biomimetics (Basel, Switzerland) · 2026Article
- Multi-UAV Cooperative Path Planning Using a Behavior-Adaptive Aquila Optimizer Under Multiple Constraints.Biomimetics (Basel, Switzerland) · 2026Article
- Efficient estimation of proton exchange membrane fuel cells parameters using a hybrid swarm intelligent algorithm.Scientific reports · 2026Article
- Prediction of PEMFC life based on IGJO-TCN-BiGRU-Attention.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parameter identification in a Proton Exchange Membrane Fuel Cell (PEMFC) entails the application of optimization algorithms to ascertain the optimal unknown variables essential for crafting an accurate model that predicts fuel-cell performance. These parameters are typically not included in the manufacturer's datasheet and must be identified to ensure precise modeling and forecasting of fuel cell behavior. This paper introduces a recently developed hybrid algorithm (Aquila Optimizer Arithmetic Algorithm Optimization (AOAAO)) that enhances the AO and AAO algorithm's efficiency through a novel mutation strategy, aimed at determining seven unknown parameters of a PEMFC during the optimization process. These parameters function as decision variables, and the objective function aimed for minimization is the sum square error (SSE) between the predicted and actual measured cell voltages. AOAAO demonstrated superior performance across various metrics, achieving an SSE minimum in comparison to other compared algorithm. AOAAO's robustness was validated through extensive testing with six commercially available PEMFCs, including BCS 500 W-PEM, 500 W SR-12PEM, Nedstack PS6 PEM, H-12 PEM, HORIZON 500 W PEM, and a 250 W-stack, across twelve case studies derived from various operational conditions detailed in manufacturers' datasheets. For each datasheet, both Current-Voltage (I/V) and Power-Voltage (P/V) characteristics of the PEMFCs scenarios closely aligned with those observed in experimental data, affirming AOAAO's superior accuracy, robustness, and time efficiency for real-time fuel cell modeling. In terms of computational efficiency, AOAAO runtime is significantly faster than all compared algorithms, demonstrating an efficiency improvement of approximately 98%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.